Novo Reports More Good News For Type 2 Diabetes Candidate Liraglutide
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III LEAD 1 trial shows GLP-1 analogue superior to rosiglitazone in glucose control when combined with glimepiride; LEAD 2 results also positive.